Drug · DIN 02413191
OCPHYL
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since June 14, 2018; first marketed May 12, 2014.
- Drug Identification Number (DIN)
- 02413191
- Company (DIN owner)
- Pendopharm Division Of Pharmascience IncMontreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Solution
- Route
- Subcutaneous; Intravenous
- Therapeutic class (ATC)
- Octreotide H01CB02
- Class
- Human
- Record last updated
- June 25, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| OCTREOTIDE (OCTREOTIDE ACETATE) | 50 MCG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 27, 2013: NOC 14766Abbreviated New Drug Submission (ANDS)
Other DINs named OCPHYL
- DIN 02413205 · Cancelled Post Market
- DIN 02413213 · Cancelled Post Market